The objective of this study was to investigate the tubular site or sites of the natriuretic action of atrial natriuretic factor (ANF) and possible differences between healthy subjects and patients with essential hypertension. Nine healthy volunteers and six patients with essential hypertension were studied on four test days under standard conditions, water loading, and hydropenia with mannitol or saline loading. On each test day baseline, ANF infusion (1 µg/min) and recovery measurements were performed after equilibrium had been reached. The measurements included the ANF plasma levels, blood pressure, glomerular filtration rate (GFR), effective renal plasma flow (ERPF), urinary osmolality, and the (fractional) excretions of (free) water, sodium, and potassium. Fractional free water excretion (C H2O /GFR) and free water reabsorption (T c H2O /GFR; as function of osmolar clearance) were calculated during water loading and hydropenia with mannitol or saline loading, respectively, using standard formulas.
I-iothalamate and 131
I-hippuran were infused continuously for measurement of GFR and ERPF, respectively. The plasma ANF concentration rose five-to eightfold during the infusion of ANF, which induced an increase in urinary sodium excretion, a small increase in GFR, and a decrease in ERPF. Moreover, ANF induced an increase in C H2O /GFR and a decrease in T c H2O /GFR. These changes did not correlate with changes in GFR. Blood pressure and potassium excretion were not affected. The effects of ANF on the plasma ANF levels, natriuresis, and renal hemodynamics did not differ between the normotensives and the patients with essential hypertension. However, the increase in C H2O /GFR was greater in patients with essential hypertension (p<0.05), and correlated significantly with blood pressure (r=0.56, p<0.05).
These results indicate that the infusion of ANF at a low dose induces a similar natriuretic response in normotensive subjects and in patients with essential hypertension. This natriuresis is probably the result of both a glomerular and a tubular effect of ANF. Proximal as well as distal tubular sites seem to be involved. In patients with essential hypertension, an enhanced proximal as well as an impaired distal tubular action of ANF can be hypothesized.
INTRODUCTION
The renal natriuretic site of action of atrial natriuretic factor (ANF) has been the subject of several studies in normotensive humans [1] [2] [3] [4] [5] [6] . These studies have indicated that at least the proximal and distal tubule are involved in ANF-induced natriuresis [1] [2] [3] . With regard to the distal tubule, Rabelink et al have provided evidence that ANF acts at the inner medullary collecting duct (IMCD) in particular [4] . ANF has also been shown to decrease urinary osmolality, which led us and others to suggest that ANF induces a washout of the medullary interstitium [5, 6] . Animal data have shown that ANF may cause such a washout of the medullary interstitium by increasing the medullary blood flow [7, 8] . Because changes in medullary tonicity affect urinary sodium excretion, probably through an effect at the loop of Henle [9] , it can be hypothesized that medullary tubular segments (i.c. Henle's loop and the IMCD) are important for ANF-induced natriuresis. In patients with essential hypertension (EH) the effects of ANF on these medullary segments have not yet been studied, although several lines of evidence indicate that ANF may act differently at these sites in EH. We and others have shown that the natriuretic effect of ANF depends on the prevailing level of the systemic blood pressure [10, 11] , and animal studies have shown that the ANF-induced increase in renal medullary blood flow is enhanced at higher levels of renal perfusion pressure [8] . It could thus be hypothesized that the higher perfusion pressure in EH [12] will enhance the effect of ANF on Henle's loop in EH. In contrast, the effect of ANF on the IMCD in Dahl saltsensitive rats has been shown to be impaired [13] .
A method to evaluate the medullary tubular site of action of a natriuretic drug is to study the effects on free water excretion (C H2O ) and reabsorption (T c H2O ) [14, 15] . An ANF-induced rise in C H2O (during water loading) is compatible with an effect at a tubular segment proximal to the point of isotonicity in the medullary ascending limb of Henle's loop, whereas a decrease in C H2O suggests an action distal from this point. An ANFinduced decrease in T c H2O (during hydropenia and mannitol or saline loading) suggests a medullary tubular site of action, whereas an increase in T c H2O implies a more cortical site of action, such as the proximal tubule.
To evaluate further the effect of ANF on renal tubular segments and to test the possible different action of ANF at these segments in EH, we investigated the natriuretic effect of ANF in relation to its effects on C H2O and T c H2O in normotensive subjects and patients with essential hypertension.
SUBJECTS AND METHODS
Nine healthy volunteers (3 female, 6 male) were enrolled in the present study. Their mean (±SEM) age was 31±5 yr (range 21-58). Systolic blood pressure (SBP) measured 123±3 mmHg (range 110-140), and diastolic blood pressure (DBP) 71±4 mmHg (range 58-86). Six patients (all male) with uncomplicated essential hypertension were also enrolled. Their mean age was 44±2 yr (range 36-53), which was not significantly different from the normotensive volunteers. SBP was 140±3 mmHg (range 134-150), and DBP 97±1 mmHg (range 96-100) were enrolled. The protocol was approved by the local Medical Ethical Committee, and all subjects gave their informed consent.
From at least 2 weeks prior to the study until the end of the study they did not receive any drug and adhered to a 200 mmol/day sodium diet. The dietary compliance was good: 24-h urine collections contained 162 ± 12 mmol Na in the normotensives (NT), and 185 ± 20 mmol Na in EH (NS). Normotensive and hypertensive subjects were studied in random order. The study consisted of four test days, each separated by 1 week and each characterized by different physiological conditions: standard conditions, water loading, hydropenia with mannitol loading, and hydropenia with saline loading. All test days started at 8 AM. The subjects assumed the supine position for the whole day, except for urine voiding. Blood pressure was recorded every 2 min with an automated non-invasive device (Dinamap ® , Critikon Inc, Tampa, Florida, USA). On the first test day all of the subjects were examined during standard conditions, consisting of an oral intake of 150 ml water every hour and 17 mmol Na every 2 hours, and a continuous intravenous infusion of 100 ml/h dextrose 5%. On the second test day a water loading experiment was performed: a steady state of urinary dilution was induced and maintained during the whole test day with an oral intake of 150 ml water every 20 min and a continuous infusion of 1000 ml/h dextrose 5%. A subgroup of the normotensive and hypertensive subjects were studied during urinary concentrating conditions; that is, hydropenia with mannitol loading (NT n=7, EH n=5) and hydropenia with saline loading (NT n=4, EH n=3): food and fluids were withheld for 14 hours before the start of the test and no oral fluids were administered during the test day. At 8 AM lypressin (350 mU vasopressin Sandoz ® , Sandoz Pharma Ltd, Basle, Swiss) was injected intramuscularly, followed by a continuous and simultaneous intravenous infusion of 350 mU lypressin/h to induce supra-maximal vasopressin concentrations and 600 ml/h mannitol 10% in 100 mM NaCl or 600 ml/h saline 3% to ensure diuresis. On all of the test days glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were measured by continuous infusion of 125 I-iothalamate and 131 I-hippuran, respectively [16] . Urine was collected by spontaneous voiding. Collections were made every hour during standard conditions and every 20 min during water loading and hydropenia. Baseline data were obtained from 10 AM to 12 AM under standard conditions. During water loading and hydropenia four consecutive baseline measurements were made after a stable diuresis had been attained (difference in urinary volume less than 2 ml/min of the mean). An intravenous infusion of 1 µg ANF/min (human ANF 101-126, MSD-RL, New Jersey, USA) was then started for 2 hours under standard conditions and water loading, and for 80 min under both hydropenia conditions. Meanwhile, the fluid infusions mentioned above were maintained. Finally, after stopping the infusion of ANF, recovery measurements were obtained for 2 hours under standard conditions and water loading, and for 80 minutes under both hydropenia conditions. Blood for the measurement of immunoreactive ANF (irANF) was drawn with the subjects in the supine position at the end of each period in prechilled tubes containing EDTA. Blood for the measurement of electrolytes, osmolality, 131 I-hippuran, and 125 I-iothalamate was sampled every hour under standard conditions, and every 40-60 min during water loading and hydropenia.
Sodium, potassium, and chloride concentrations in urine and serum were measured using standard autoanalyzer techniques (Technicon Instr Corp, Tarrytown, New York, USA). Urinary and serum osmolality were measured using the method of freezing point depression (Osmomat-030, Gonotec GmbH, Berlin, Germany). Hippuran and iothalamate radioactivities were measured in a gammacounter (1282 Compugamma, LKB-Wallac, Turku, Finland). Immunoreactive ANF (irANF) was measured after extraction with a commercially available radioimmunoassay (INCSTAR, Stillwater, Minnesota, USA), as described previously [17] .
Clearances were calculated using the extrapolated mid-collection serum value. C osm , C H2O , and T c H2O were calculated as: C osm = (U osm ×V)/P osm , C H2O =V-C osm , and T c H2O =C osm -V, where U osm and P osm are osmolalities of urine and serum, respectively (mOsm/kg H2O), and V is urinary flow (ml/h). Fractional free water excretion (C H2O /GFR) during maximal water diuresis was taken as an index of sodium reabsorption in the diluting segment, i.e distal of the point of isotonicity in the medullary ascending limb of Henle's loop. The changes in fractional free water plus chloride clearance ((C H2O +C Cl )/GFR) were regarded as an index of the changes in fractional solute delivery to the diluting segment, and changes in the ratio (C H2O /(C H2O +C Cl )) were regarded as an index of changes in the diluting segment reabsorption [14, 15] . The changes in these parameters were compared to the mean of the four baseline values. However, changes in T c H2O can be interpreted only in terms of their relationship to the changes in C osm [14, 15] . Since ANF increased C osm , changes in T c H2O needed a different evaluation. We therefore extrapolated the curvilinear relationship between baseline T c H2O and C osm values using a semilogarithmic approximation [18] . The expected values for T c H2O during the infusion of ANF and recovery could be calculated at the observed levels of C osm . The ANF-induced changes in T c H2O were interpreted as the difference between the measured and expected value at the actual C osm level. Recovery values returned to the extrapolated curve, justifying these calculations. Nevertheless, this necessitates some caution in the interpretation of these clearance data. ERPF was calculated using the continuous infusion method and GFR with the standard method, corrected for incomplete collection of urine as described previously [16] . For the calculation of fractional clearances, GFR as measured with the standard method was used. Filtration fraction (FF) was calculated as the ratio of GFR to ERPF.
Statistical analysis was performed using two-way-analysis of variance with repeated measurements followed by Student's t-test for paired or unpaired samples. Data were tested against the mean of the 2 or 4 baseline values. Pearson's correlation coefficient was used to calculate correlation between variables. Differences were considered statistical significant when p<0.05.
RESULTS
Baseline (endogenous) plasma irANF was significantly lower in EH than in the normotensives during standard conditions (p<0.05, Table 1 ) as well as during water loading (p<0.05, Table 2 ). A similar difference tended to be present during both saline and mannitol loading. Mean arterial pressure was higher in EH during all tests. The other differences in baseline values were a lower ERPF in EH under all of the test conditions, a higher plasma osmolality in EH during water loading, and a higher plasma osmolality, and absolute urinary volume and sodium excretion in EH during hydropenia with mannitol loading (all p<0.05, Table 3 ). Baseline sodium excretion in EH also tended to be higher during the other test days, but the difference was not statistically significant. No further differences in the baseline data were present between the two groups.
Standard conditions
During standard conditions infusion of ANF induced an increase in urinary absolute (U Na V) and fractional (C Na /GFR) sodium excretion in the normotensive and EH subjects (p<0.05, Table 1 ). The magnitude of this ANF-induced natriuresis did not differ between the two groups (Table 1, Figure 1 ). There was no increase in urinary potassium excretion during ANF infusion. Urinary osmolality decreased upon ANF infusion, although this decrease was significant only in the EH group. Interpretation of (a lack of) differences in ANF-induced natriuresis between NT and EH should take into account possible differences in the effects of the infusion of ANF on plasma composition, plasma irANF, mean arterial pressure (MAP), or renal hemodynamics. However, the effects of ANF infusion on plasma sodium and osmolality, plasma irANF and MAP were similar in both groups. Plasma sodium and osmolality did not change. Plasma irANF level increased approximately sevenfold in both groups during ANF infusion (Table 1) , and MAP did not change during these two hours of ANF infusion. The effects of ANF on renal hemodynamics were also similar in both groups: ANF caused a small but significant increase in GFR and a distinct decrease in ERPF in both groups (Table 1) . FF thus rose significantly in both groups. The ANF-induced effects on irANF, MAP, and renal hemodynamics (Tables 2-4) in the other tests were similar to those during standard conditions in both groups. During the recovery phase (in all test conditions) all of the parameters returned towards their baseline levels in both groups.
Water loading
During water loading conditions the ANF-induced natriuresis again was found to be similar in NT and EH subjects (Table 2, Figure 1 ). ANF infusion did not cause urinary potassium excretion to change. Minimal urinary osmolality during maximal water loading tended to increase in both groups, with the ANF-induced change being statistically significant only for the combined data from both groups. Filtered load, being the product of plasma osmolality and GFR may affect parameters of free water clearance. Baseline plasma osmolality was higher in EH, whereas plasma sodium was similar in both groups. Neither was affected by ANF infusion. GFR values did not differ between both groups, nor did the response to ANF infusion. This infusion caused filtered load to increase similarly in both groups, although the increase reached statistical significance only in the normotensives. Free water clearance (C H2O ) increased after ANF infusion to a similar extent in both groups. The (absolute) increase in C H2O correlated with the increase in GFR (r=0.61, p<0.05), but not with mean arterial pressure in the second hour of ANF infusion (r=0.07, NS). In contrast, the data on fractional free water excretion (C H2O /GFR) showed clear differences between NT and EH subjects (Table 2, Figure 2 ). Fractional free water excretion (C H2O /GFR) rose significantly after the infusion of ANF in both groups (NT p<0.02, EH p<0.002, Table 2 ), the increase being significantly greater in EH (p<0.05, Figure 2 ). Similarly, (C H2O +C Cl )/GFR, indicating distal delivery, rose significantly after the infusion of ANF in both groups (NT p<0.02, EH p<0.002, Table 2 ). Again, this increase was significantly greater in EH (p<0.05). Analysis of the combined data for both groups showed a significant correlation between mean arterial pressure and the ANF-induced changes in C H2O /GFR (r=0.56, p<0.05, Figure 3 ) and in (C H2O +C Cl )/GFR (r=0.55, p<0.05). There were no correlations with the increase in GFR (r=0.04, NS, and r=0.11, NS, respectively). Thus, the proximal tubular natriuretic effect of ANF in EH appears to be enhanced, which may be related to the level of blood pressure. C H2O /(C H2O +C Cl ), indicating distal reabsorption, decreased in both groups (both p<0.05). The ANF-induced change in this parameter was not statistically different between the two groups. 
Hydropenia
During both hydropenia conditions (with mannitol and saline loading, respectively), the ANF-induced natriuresis was again similar in both groups, and the urinary potassium excretion was not affected (Tables 3 and 4, Figure 1 ). The ANF-induced (absolute) increase in C Na /GFR was higher during the hydropenia tests than during the tests under standard conditions or water loading in both groups (p<0.05). Analysis of the data for all four test days combined showed that this could be related to a significant correlation between baseline C Na /GFR and its (absolute) increase. These parameters correlated significantly and similarly both in NT-subjects (r=0.52, p<0.05), and in EH-patients (r=0.55, p<0.05). Urinary osmolality was significantly decreased by the infusion of ANF in both groups, without a significant difference between the two groups. During ANF infusion plasma osmolality increased similarly in both groups. GFR values and the ANFinduced increase in GFR were similar in both groups. Since ANF caused fractional osmolar clearance (C osm /GFR) to increase (by approximately 30 per cent in both groups; (Tables 3 and 4 Data are expressed as mean ± sem as measured for baseline over 4 periods, and for ANF infusion and recovery over the last 40 minutes. *=p<0.05 ANF vs baseline. #=p<0.05 hypertensives vs normotensives, indicated only for the baseline values. $=p<0.05 ANF response hypertensives vs normotensives.
DISCUSSION
In the present study we found that low dose ANF infusion induces a similar natriuretic effect in normotensive and EH subjects. Moreover, the present data show that the ANF-induced increase in C H2O /GFR correlates with blood pressure and is enhanced in EH compared with NT.
Our observation of a similar ANF-induced (overall) natriuretic effect in normotensive and EH subjects (under all of the present test conditions) is in good agreement with other recent studies that have used low doses of ANF [19] . However, for several reasons ANF-induced natriuresis would be expected to be enhanced in EH. First, considerable evidence exists from animal experiments that the ANF-induced rise in urinary sodium excretion depends rather strongly on blood pressure [20] . Similarly, in patients with secondary hypertension a dose of ANF comparable with that used in the present study Data are expressed as mean ± sem as measured for baseline over 4 periods, and for ANF infusion and recovery over the last 40 minutes. Statistical analysis was not performed for the test with hydropenia and saline loading since too few subjects were involved.
has been shown to induce a greater natriuretic response than in normotensive controls. Moreover, the natriuretic effect of ANF was shown to correlate with blood pressure [21] . The first studies in EH used higher doses of ANF and showed an enhanced ANF-induced natriuretic response in EH [11] . In that study ANF-induced natriuresis also was found to correlate with the prevailing blood pressure level. We have found that the ANF-induced natriuresis in EH is positively influenced by the blood pressure level even during the infusion of very low doses of ANF [10] . Secondly, differences in sodium or volume status may change the overall ANF-induced natriuresis. This possibility is supported by our observation that ANF-induced natriuresis is enhanced at higher baseline levels of urinary sodium excretion, in agreement with the literature on this topic [22, 23] . Since baseline urinary sodium excretion tended to be higher in EH under all four test conditions, our observation of a similar natriuretic response in both groups again suggests a relative hyposensitivity in EH to ANF. Therefore, in our opinion, as has been hypothesized by others [19] , the absence of an enhanced natriuretic effect in the presence of a higher blood pressure suggests a relative hyporesponsiveness of EH to ANF. The discrepancies between studies on the natriuretic effect of ANF in EH can be explained in terms of the clear differences in the dose of ANF, if it is hypothesized that a subtle hyporesponsiveness of EH to ANF is overcome at higher doses. As far as the natriuretic mechanism of action of ANF is concerned, this mechanism appears to be complex, and glomerular as well as proximal and distal tubular effects of ANF have been suggested [1] [2] [3] [4] 6, 24] . In the present study we observed a small but significant ANF-induced increase in GFR, which was similar in both groups under all four test conditions. Other studies using low doses of ANF did not find that ANF increased GFR [3, 19, 25] , whereas in some studies using higher doses the ANF-induced increases in GFR were not statistically significant [1, 2, 4 ]. An increase in GFR certainly contributes to an increase in urinary sodium excretion and may even effect the parameters of tubular sodium handling. For instance, we observed the ANF-induced increase in C H2O correlated with the increase in GFR. However, in the low dose human ANF studies, which showed no change in GFR, tubular effects of ANF are held to be responsible for the observed urinary changes. The present study also supports the possibility of there being tubular sites of action of ANF.
From the present study proximal as well as distal tubular actions of ANF may be suggested to be involved in both NT and EH subjects. In favour of a distal tubular action of ANF are the absence of an increase in urinary potassium excretion under all of the test conditions, and the ANF-induced decrease in C H2O /(C H2O +C Cl ), an index of diluting segment reabsorption and the increase in the minimal urinary osmolality during water loading [14, 15] . These findings are consistent with previous studies [4] . Both the absence of an ANF-induced increase in urinary potassium excretion and the increase in minimal urinary osmolality cannot be attributed to an increase in GFR. A distal tubular effect of ANF is further supported by studies showing distal ANF receptors in animals as well as in humans and animal micropuncture studies showing distal ANF effects [26] [27] [28] . The absence of a kaliuretic effect may suggest an action at the inner medullary collecting duct as suggested by Rabelink et al [4] . The main argument in favour of a proximal tubular action of ANF is the observed increase in C H2O /GFR. This increase in C H2O /GFR correlated with blood pressure and not with GFR, which suggests at least a hemodynamically mediated ANF effect at a tubular site before the point of isotonicity. Blood pressure related renal effects are shown to be mediated by changes in sodium reabsorption in the proximal convoluted tubule [29, 30] or the thin descending limb of Henle [29, 31] , or both. Moreover, pressure-related natriuresis is associated with increases in the medullary blood flow, and ANF has been shown in animal experiments to increase the medullary blood flow. Our observation that ANF decreases urinary osmolality may be in agreement with such an effect. Finally, we found that ANF decreased T c H2O /GFR. Within the limits of this test, this suggests a medullary tubular site of action [14, 15] . This decrease in T c H2O /GFR did not correlate with the increase in GFR. Therefore, although it remains hard to assess the significance of the possible effect of the observed increase in GFR on the parameters of fractional free water clearance or reabsorption, we suggest that the ANF-induced natriuresis is due to the combined effects of a small increase in GFR and (direct or hemodynamically mediated) distal and proximal tubular sites of action in humans.
The enhanced ANF-induced rise in C H2O /GFR in EH and the correlation with blood pressure suggest an enhanced delivery of sodium to the diluting segments in EH, which is not, however, accompanied by an enhanced natriuresis. In addition, this enhanced increase in C H2O /GFR in EH could be explained by an attenuated ANF effect at a distal tubular site. Such an additional diminished distal action of ANF may then also explain its similar natriuretic effect in EH. Interestingly, in Dahl salt-sensitive rats a hyposensitivity to ANF has been found in the IMCD [13] . Moreover, a diminished ANF immunoreactivity at distal tubular segments has been reported in hypertensive patients [27] , similar to that found in spontaneously hypertensive rats [26] . Such a distal hyporesponsiveness to ANF could be a primary defect underlying the development of hypertension, or an adaptive process to prevent sodium loss from (ANF-related) pressure natriuresis. This cannot be concluded from the present study. Alternatively, other mechanisms may be operative. For instance, the interpretation of the changes in C H2O /GFR is based on the assumption that secretion of antidiuretic hormone is suppressed [14] . If this was not achieved, then the results can be explained by an enhanced inhibition of the action of antidiuretic hormone by ANF in EH. However, the water load used in the present study was large. Moreover, we did not replace the voided urinary volume. Since in EH the ANF-induced increase in urinary volume excretion tended to be larger than in the normotensives, the enhanced increase in C H2O /GFR in EH is probably underestimated. We therefore hypothesize that both the observed similar natriuretic action of ANF in EH and the associated enhanced change in C H2O /GFR could be explained by an enhanced (blood pressure related) delivery of sodium to the diluting segments together with an impaired natriuretic response at more-distal tubular segments.
In conclusion, the present data show that the overall natriuretic response to ANF in EH is similar to that in normotensive subjects during different states of volume loading. The data suggest glomerular as well as proximal and distal tubular effects of action of ANF. From these data an enhanced proximal and an impaired distal tubular action of ANF in EH can be hypothesized.
